Stay updated on Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T17:17:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a general 'Gastric cancer' term and a link to the Genetic and Rare Diseases Information Center, and updated the page revision to v3.4.2; these are minor metadata and labeling updates that do not change core study content or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T05:09:25.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 (replacing v3.4.0); no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T04:44:09.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    UI and metadata updates include a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' timestamp in Study Record Dates, and the 'Revision: v3.4.0' label, with 'No FEAR Act' shown as 'No FEAR Act data'.
    Difference
    0.1%
    Check dated 2026-01-23T21:44:12.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-17T01:32:53.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added state-level Locations (California, Kansas, Massachusetts, New York, Texas, Washington) and removed the corresponding state locations; Revision: v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-19T11:34:32.000Z thumbnail image

Stay in the know with updates to Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab with Paclitaxel in Gastric Cancer Clinical Trial page.